Sana Biotechnology, Inc. (SANA) › Operating IncomeSana Biotechnology, Inc. (SANA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$141.15M2020: -$286.15M2021: -$356.91M2022: -$272.56M2023: -$293.14M2024: -$272.72M2025: -$250.32M-$250.32M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$250.32M+8.2%2024-$272.72M+7.0%2023-$293.14M-7.5%2022-$272.56M+23.6%2021-$356.91M-24.7%2020-$286.15M-102.7%2019-$141.15M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share